Abstract Coronavirus disease 2019 (COVID-19) predisposes patients to thrombotic and
thromboembolic events, owing to excessive inflammation, endothelial cell activation and …

COVID-19 is a primary respiratory illness that is frequently complicated by systemic
involvement of the vasculature. Vascular involvement leads to an array of complications …

Objective To quantify the risk of deep vein thrombosis, pulmonary embolism, and bleeding
after covid-19. Design Self-controlled case series and matched cohort study. Setting …

COVID-19 patients have a high incidence of thrombosis, and thromboembolic complications
are associated with severe COVID-19 and high mortality. COVID-19 disease is associated …

Infection with the SARS-CoV-2 virus, resulting in COVID-19 disease, has presented a
unique scenario associated with high rates of thrombosis. The risk of venous thrombosis is …

Abstract Coronavirus disease 2019 (COVID-19) associated coagulopathy is multifactorial
and involves inflammation driven hypercoagulability, endothelial dysfunction, platelet …

By January 2022 over ten billion doses of COVID-19 vaccines had been administered
worldwide. Concerns about COVID-19 vaccine-associated thrombosis arose after the …

Abstract The coronavirus disease 2019 (COVID-19) pandemic has posed a burden to
healthcare systems around the world and has changed the way people access health …

Coronavirus disease 2019 (COVID-19)-associated coagulopathy is an acute illness
characterized by thrombosis with or without hemorrhage after COVID-19 infection. Clinical …

From the data in our possession derived from the literature, it has been shown that men
have a high risk and appear to have a specific higher risk of suffering from thromboembolism …